To include your compound in the COVID-19 Resource Center, submit it here.

Adolor regains Entereg rights

Adolor Corp. (NASDAQ:ADLR) will regain full U.S. rights from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to Entereg

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE